Intrinsic Value
Karyopharm Therapeutics Inc. (KPTI)
$1.17
-0.11 (-8.59%)
Enterprise Value | -23,728.15 |
---|---|
Net Debt | 124.13 |
Equity Value | -23,852.28 |
Shares Outstanding | 114.22 |
Equity Value Per Share | -208.83 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt